These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 8751088

  • 1. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP, Michaud JC, Le Fur G, Soubrié P.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
    Lees G, Dougalis A.
    Brain Res; 2004 Jan 30; 997(1):1-14. PubMed ID: 14715144
    [Abstract] [Full Text] [Related]

  • 3. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F.
    J Neurosci; 2002 Nov 01; 22(21):9612-7. PubMed ID: 12417686
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
    Steffens M, Szabo B, Klar M, Rominger A, Zentner J, Feuerstein TJ.
    Neuroscience; 2003 Nov 01; 120(2):455-65. PubMed ID: 12890515
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
    Kim D, Thayer SA.
    J Neurosci; 2001 May 15; 21(10):RC146. PubMed ID: 11319244
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K, Molleman A, Parsons M, Whelan C.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):207-15. PubMed ID: 12620515
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696
    [Abstract] [Full Text] [Related]

  • 14. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice.
    Collins DR, Pertwee RG, Davies SN.
    Br J Pharmacol; 1995 Jul 01; 115(6):869-70. PubMed ID: 7582512
    [Abstract] [Full Text] [Related]

  • 15. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
    Silva GB, Atchison DK, Juncos LI, García NH.
    Am J Physiol Renal Physiol; 2013 Feb 15; 304(4):F376-81. PubMed ID: 23220721
    [Abstract] [Full Text] [Related]

  • 16. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC.
    Biochem Pharmacol; 2007 Jun 15; 73(12):2004-11. PubMed ID: 17445778
    [Abstract] [Full Text] [Related]

  • 17. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
    Vivian JA, Kishioka S, Butelman ER, Broadbear J, Lee KO, Woods JH.
    J Pharmacol Exp Ther; 1998 Aug 15; 286(2):697-703. PubMed ID: 9694923
    [Abstract] [Full Text] [Related]

  • 18. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
    Shim JY, Welsh WJ, Cartier E, Edwards JL, Howlett AC.
    J Med Chem; 2002 Mar 28; 45(7):1447-59. PubMed ID: 11906286
    [Abstract] [Full Text] [Related]

  • 19. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
    Ho WS, Gardiner SM.
    Br J Pharmacol; 2009 Jan 28; 156(1):94-104. PubMed ID: 19133994
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH, Oriowo MA.
    Pharmacol Res; 1999 Nov 28; 40(5):415-21. PubMed ID: 10527656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.